Difficulty: Medium
Average Score: 64%
Practice
Methylergonovine (Methergine®) may be administered to a woman after delivery in order to
Correct answer
A
Rationale
In the context of the female reproductive system, Methylergonovine (Methergine®) is administered after delivery to promote uterine contractions. This is the correct option (A) because Methylergonovine is a uterotonic medication that helps the uterus to contract, preventing postpartum hemorrhage by reducing the risk of excessive bleeding after childbirth.
Option B, relieving pain and discomfort, is not the primary purpose of Methylergonovine. While some pain relief may occur as a result of improved uterine tone, the main goal is to prevent hemorrhage.
Option C, reducing maternal hypertension, is incorrect. Methylergonovine is not used to treat hypertension but rather to facilitate uterine contractions.
Educationally, understanding the role of Methylergonovine in promoting uterine contractions post-delivery is crucial for healthcare providers working in obstetrics to ensure proper postpartum care and prevent complications like postpartum hemorrhage. Knowing the correct administration and effects of this medication can help save lives and promote the well-being of mothers and babies.
Option B, relieving pain and discomfort, is not the primary purpose of Methylergonovine. While some pain relief may occur as a result of improved uterine tone, the main goal is to prevent hemorrhage.
Option C, reducing maternal hypertension, is incorrect. Methylergonovine is not used to treat hypertension but rather to facilitate uterine contractions.
Educationally, understanding the role of Methylergonovine in promoting uterine contractions post-delivery is crucial for healthcare providers working in obstetrics to ensure proper postpartum care and prevent complications like postpartum hemorrhage. Knowing the correct administration and effects of this medication can help save lives and promote the well-being of mothers and babies.